Nutritional Management for Infants with Cystic Fibrosis Born with Meconium Ileus: A 15-Year Review

Susan Gemma1, Anne Rice1, Rosara Bass2,3

  • 1Division of Pulmonary, Sleep Medicine and Cystic Fibrosis, Nationwide Children's Hospital, Columbus, OH 43205, USA.

Nutrients
|August 13, 2026
PubMed

Insights

Infants with cystic fibrosis and meconium ileus require prolonged hospitalization and nutritional support. Ostomy placement significantly increases length of stay and total parenteral nutrition duration.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatal Nutrition
  • Cystic Fibrosis Research

Background:

  • Meconium ileus (MI) in newborns with cystic fibrosis (CF) presents significant nutritional management challenges.
  • Understanding clinical outcomes and management practices is crucial for improving care.

Purpose of the Study:

  • To describe the management practices and clinical outcomes of infants with CF and MI.
  • To analyze factors influencing outcomes in this patient population.

Main Methods:

  • Retrospective analysis of 30 neonates with CF and MI over 15 years.
  • Data collected included demographics, imaging, genetic data, and clinical course.
  • Outcomes compared between infants with and without surgical ostomy.

Main Results:

  • 26 infants required surgery, 18 with ostomy placement.
  • Ostomy placement correlated with significantly longer hospital stays (median 71 vs. 22 days) and TPN duration (median 52 vs. 8 days).
  • No significant correlations found between MI severity markers (genotype, elastase, imaging) and ostomy need.

Conclusions:

  • Infants with CF and MI have complex medical needs requiring extended hospitalization and TPN.
  • Institutional approaches to nutritional management emphasize multidisciplinary collaboration.
  • This case series provides insights into managing this challenging condition.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...